Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Wedbush Maintains Outperform on Cresco Labs, Raises Price Target to $3

Author: Benzinga Newsdesk | May 16, 2024 08:58am
Wedbush analyst Gerald Pascarelli maintains Cresco Labs (OTC:CRLBF) with a Outperform and raises the price target from $2.5 to $3.

Posted In: CRLBF